mRNA
An expert’s opinion: An interview with Ayman El-Mohandes on COVID-19 vaccine acceptance and public health messaging
Ayman El-Mohandes, Dean of City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) and co-coordinator of a global survey on potential hesitancy to accept a proven, safe and effective COVID-19 vaccine, speaks to us about the findings and their implications for halting the spread of the virus. What does ...
An expert’s opinion: An interview with Melinda Mills on the behavioural factors underlying COVID-19 vaccine uptake
We speak with Melinda Mills, Director of the Leverhulme Centre for Demographic Science at the University of Oxford and lead author of the British Academy and Royal Society report on Vaccine Deployment. She calls for open dialogue about vaccine concerns and the need to help people spot misinformation. How did the Vaccine Deployment report come ...
Vaccination policy in times of Covid-19
As multiple COVID-19 vaccines are emerging, what can be done to tackle vaccination hesitancy and ensure rapid and equitable deployment?
A scientist’s opinion : Interview with Dr Kari Johansen about vaccine procedure
Dr Kari Johansen is expert in influenza and other respiratory viruses and vaccine-preventable diseases at the ECDC. She obtained her medical degree from the Karolinska Institute in Stockholm, where she also did her PhD (1999). Prior to joining the European Centre for Disease Prevention and Control (ECDC) in 2008, Dr Johansen worked for the Swedish ...
A scientist’s opinion : Interview with Marco Cavaleri about vaccine procedure
Marco Cavaleri is Head of Office, Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA). He is also the chair of the COVID-19 EMA pandemic Task Force and is responsible for EMA activities regarding emerging pathogens, vaccines and antimicrobial resistance. He is a pharmacologist who has spent several years in industry in ...
COVID-19: ensuring a safe and effective vaccine
Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) for their thoughts.